Pregnancy Preterm Birth

An extra-uterine system to physiologically support the extreme premature lamb

Partridge EA, Davey MG, Hornick MA, McGovern PE, Mejaddam AY, Vrecenak JD, Mesas-Burgos C, Olive A, Caskey RC, Weiland TR, Han J, Schupper AJ, Connelly JT, Dysart KC, Rychik J, Hedrick HL, Peranteau WH, Flake AW

Published April 25, 2017 Nature communications, 8, 15112
DOI 10.1038/ncomms15112 PMID 28440792 PMC PMC5414058

RRM Academy Synopsis

Extra-uterine device supported extremely premature lambs up to 4 weeks

An extra-uterine device supported fetal lambs, equal in development to extremely premature infants, for up to 4 weeks. Among 8 lambs on the final design, circulation stayed steady and growth was comparable to controls. Their lung and brain measures were similar to age-matched controls.

Study at a glance, preclinical device study: An extra-uterine device supported extremely premature lambs up to 4 weeks
Study at a glance, preclinical device study of 8 lambs on the final design: An extra-uterine device supported extremely premature lambs up to 4 weeks. Source: Partridge EA et al., 2017, PMID 28440792.

Key Findings

  • Eight lambs on the final design were supported for 20 to 28 days: five at 105 to 108 days of gestation, three at 115 to 120 days (term is 145 days).
  • Final-design lambs had circuit flow comparable to normal placental flow. Their transfusion needs were lower than with the earlier carotid artery design, and the last three, given erythropoietin, needed none.
  • Growth in the final-design lambs was comparable to breed-matched controls. Lungs advanced from the canalicular to the saccular stage in parallel with age-matched controls, and the lambs were easily ventilated after removal.
  • In final-design lambs, brain-to-body weight ratio, gyral thickness and myelin density did not differ from age-matched controls. Blinded neuropathologists found no lesions of ischemia, infarction or demyelination.
  • The closed fluid bag eliminated pneumonia on lung pathology. The longest runs ended at 28 days because of animal protocol limits.

Interpretation

The paper is a preclinical device study in fetal lambs at Children's Hospital of Philadelphia. Eight animals ran on the final design. Controls were age-matched lambs and published fetal data; two insulin-treated lambs were excluded from brain growth measures. Lamb lungs at 106 to 113 days of gestation match those of a premature infant at 23 to 24 weeks. The authors state that the sheep model cannot assess the risk of bleeding in the brain (intracranial hemorrhage). Clinical use will require further scientific and safety validation. They name infants at 23 to 25 weeks as the likely first clinical target.

RRM Context

Restorative reproductive medicine is cause-based and couple-centered. It evaluates the conditions that affect a pregnancy before treating them, with the goal of supporting a pregnancy that stays in the womb. The lamb device imitates parts of what a pregnancy supplies: gas exchange, fluid, circulation and nutrition. The authors call extreme prematurity the leading cause of newborn death and illness in the developed world.

Abstract

In the developed world, extreme prematurity is the leading cause of neonatal mortality and morbidity due to a combination of organ immaturity and iatrogenic injury. Until now, efforts to extend gestation using extracorporeal systems have achieved limited success. Here we report the development of a system that incorporates a pumpless oxygenator circuit connected to the fetus of a lamb via an umbilical cord interface that is maintained within a closed 'amniotic fluid' circuit that closely reproduces the environment of the womb. We show that fetal lambs that are developmentally equivalent to the extreme premature human infant can be physiologically supported in this extra-uterine device for up to 4 weeks. Lambs on support maintain stable haemodynamics, have normal blood gas and oxygenation parameters and maintain patency of the fetal circulation. With appropriate nutritional support, lambs on the system demonstrate normal somatic growth, lung maturation and brain growth and myelination.

Topics

By this author

Pregnancy › Preterm Birth › Tocolytic Therapy
Emily A Partridge, Marcus G Davey, Matthew A Hornick, Patrick E McGovern, Ali Y Mejaddam, Jesse D Vrecenak, Carmen Mesas-Burgos, Aliza Olive, Robert C Caskey, Theodore R Weiland, Jiancheng Han, Alexander J Schupper, James T Connelly, Kevin C Dysart, Jack Rychik, Holly L Hedrick, William H Peranteau, Alan W Flake
E Partridge, M Davey, Matt Hornick, M Hornick, Pat McGovern, P McGovern, A Mejaddam, J Vrecenak, C Mesas-Burgos, A Olive, Bob Caskey, Rob Caskey, Bobby Caskey, R Caskey, T Weiland, J Han, Alex Schupper, A Schupper, Jim Connelly, Jimmy Connelly, J Connelly, K Dysart, John Rychik, J Rychik, H Hedrick, Bill Peranteau, Will Peranteau, Billy Peranteau, W Peranteau, A Flake
PMID 28440792 28440792 DOI 10.1038/ncomms15112 10.1038/ncomms15112 Partridge et al. 2017, Partridge 2017